secwatch / observer
8-K filed December 22, 2025, 6:59 PM ET ticker VREOF CIK 0001771706
M&A confidence high sentiment positive materiality 0.75

Vireo Growth to acquire 17 Colorado dispensaries from PharmaCann for ~$49M in shares

Vireo Growth Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Vireo Growth Inc. entered into APA with PharmaCann Inc., certain of PharmaCann's subsidiaries, and Argent Institutional Trust Company valued at $49,000,000.00 (effective 2025-12-16).

Action
entry
Agreement
asset purchase
Counterparty
PharmaCann Inc., certain of PharmaCann's subsidiaries, and Argent Institutional Trust Company
Value
$49,000,000.00
Effective
2025-12-16
Exact text from the filing
On December 16, 2025, Vireo Health, Inc. (“ Buyer ”), a Delaware corporation and wholly owned subsidiary of Vireo Growth Inc. (the “ Company ”), the Company, PharmaCann Inc., a Delaware corporation (“ PharmaCann ”), certain of PharmaCann’s subsidiaries (collectively, with PharmaCann the “ Seller Parties ”), and Argent Institutional Trust Company (“ Agent ”), as collateral agent under the Indenture, dated as of June 24, 2021, by and among PharmaCann, as issuer, the Guarantors (as defined thereunder) party thereto, including the Seller Parties, and Agent, as trustee and collateral agent thereunder, entered into an Asset Purchase Agreement (the “ APA ”).
View on SEC.gov

622 material agreements filed in the last 30 days. Browse all material agreements →

Vireo Growth Inc. filing history →

Source: SEC EDGAR
accession 0001104659-25-123459
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.